Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01165710|
Recruitment Status : Completed
First Posted : July 20, 2010
Last Update Posted : January 24, 2017
|Condition or disease||Intervention/treatment|
|Atrial Fibrillation||Other: Patients with Atrial Fibrillation (AF)|
|Study Type :||Observational|
|Actual Enrollment :||10179 participants|
|Official Title:||Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)|
|Study Start Date :||June 2010|
|Actual Primary Completion Date :||November 2014|
|Actual Study Completion Date :||December 2014|
Patients with Atrial Fibrillation (AF) Treatment patterns of AF according to patient demographics clinical factors risk stratification and geographic regions.
Other: Patients with Atrial Fibrillation (AF)
Treatment patterns of AF according to patient demographics, clinical factors, risk stratification, and geographic regions.
- The primary outcome is stroke or non-CNS (systemic) embolism. Key primary objective is: characterize & describe the AF patient population as a whole, with emphasis on demographics, comorbidities, and risk profiles. [ Time Frame: 3 years ]
- The number of major adverse cardiac events. [ Time Frame: 3 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01165710
|Study Director:||Janssen Scientific Affairs, LLC Clinical Trial||Janssen Scientific Affairs, LLC|